Skip to main content
PMC home page
Gut logoLink to Gut
. 1994 Apr;35(4):471–475. doi: 10.1136/gut.35.4.471

Localisation of neuroendocrine tumours of the upper gastrointestinal tract.

T Zimmer 1, K Ziegler 1, M Bäder 1, U Fett 1, B Hamm 1, E O Riecken 1, B Wiedenmann 1
PMCID: PMC1374794  PMID: 8174983

Abstract

In order to localise neuroendocrine tumours of the foregut type (that is, of the stomach, duodenum, and pancreas), 18 patients were studied prospectively by endoscopic ultrasonography, computed tomography, transabdominal ultrasonography, magnetic resonance imaging, and somatostatin receptor scintigraphy. These 18 patients had a total of 25 primary tumour lesions which were verified histologically in tissue obtained by surgery or by ultrasound or endoscopy guided biopsy. Tumours were found in the stomach (n = 1), duodenum (n = 6), pancreas (n = 17), and liver (n = 1). Endoscopic ultrasonography had the highest sensitivity for tumour detection, followed by somatostatin receptor scintigraphy, computed tomography, transabdominal ultrasonography, and magnetic resonance imaging (88%, 52%, 36%, 32%, and 24% respectively). Endoscopic ultrasonography was especially sensitive in tumours smaller than 2 cm in diameter (88% v somatostatin receptor scintigraphy 35%; computed tomography 12%; transabdominal ultrasonography 6%; and magnetic resonance imaging 0%). Of 17 tumours located in the pancreas, endoscopic ultrasonography showed a sensitivity of 94% (somatostatin receptor scintigraphy 47%; computed tomography 47%; transabdominal ultrasonography 41%; and magnetic resonance imaging 29%). Of eight extrapancreatic tumours, six were identified by endoscopic ultrasonography, five by somatostatin receptor scintigraphy, and only one by computed tomography, transabdominal ultrasonography, and magnetic resonance imaging. One neuroendocrine tumour that was not detected by endoscopic ultrasonography was correctly identified by somatostatin receptor scintigraphy. Endoscopic ultrasound allowed correct determination of the tumour size and tumour spread into parapancreatic structures, especially the large vessels (T stage), in all 14 patients operated upon. The lymph node stage (N stage) was correctly determined in 10 of these 14 patients. In summary, endoscopic ultrasonography and somatostatin receptor scintigraphy were the most sensitive imaging methods for the localisation of these tumours and should be used as early diagnostic procedures to accurately stage neuroendocrine tumours of the foregut type.

Full text

PDF
472

Images in this article

473Figure 1
on p.473
474Figure 2
on p.474

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Broughan T. A., Leslie J. D., Soto J. M., Hermann R. E. Pancreatic islet cell tumors. Surgery. 1986 Jun;99(6):671–678. [PubMed] [Google Scholar]
  2. Böttger T. C., Weber W., Beyer J., Junginger T. Value of tumor localization in patients with insulinoma. World J Surg. 1990 Jan-Feb;14(1):107–114. doi: 10.1007/BF01670557. [DOI] [PubMed] [Google Scholar]
  3. Frucht H., Doppman J. L., Norton J. A., Miller D. L., Dwyer A. J., Frank J. A., Vinayek R., Maton P. N., Jensen R. T. Gastrinomas: comparison of MR imaging with CT, angiography, and US. Radiology. 1989 Jun;171(3):713–717. doi: 10.1148/radiology.171.3.2655004. [DOI] [PubMed] [Google Scholar]
  4. Frucht H., Norton J. A., London J. F., Vinayek R., Doppman J. L., Gardner J. D., Jensen R. T., Maton P. N. Detection of duodenal gastrinomas by operative endoscopic transillumination. A prospective study. Gastroenterology. 1990 Dec;99(6):1622–1627. doi: 10.1016/0016-5085(90)90466-e. [DOI] [PubMed] [Google Scholar]
  5. Galiber A. K., Reading C. C., Charboneau J. W., Sheedy P. F., 2nd, James E. M., Gorman B., Grant C. S., van Heerden J. A., Telander R. L. Localization of pancreatic insulinoma: comparison of pre- and intraoperative US with CT and angiography. Radiology. 1988 Feb;166(2):405–408. doi: 10.1148/radiology.166.2.2827232. [DOI] [PubMed] [Google Scholar]
  6. Glover J. R., Shorvon P. J., Lees W. R. Endoscopic ultrasound for localisation of islet cell tumours. Gut. 1992 Jan;33(1):108–110. doi: 10.1136/gut.33.1.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Günther R. W., Klose K. J., Rückert K., Kuhn F. P., Beyer J., Klotter H. J., Cordes U. Islet-cell tumors: detection of small lesions with computed tomography and ultrasound. Radiology. 1983 Aug;148(2):485–488. doi: 10.1148/radiology.148.2.6306722. [DOI] [PubMed] [Google Scholar]
  8. Hemmingsson A., Lindgren P. G., Lörelius L. E., Oberg K. Diagnosis of endocrine gastrointestinal tumours. Acta Radiol Diagn (Stockh) 1981;22(6):657–662. doi: 10.1177/028418518102200606. [DOI] [PubMed] [Google Scholar]
  9. Krenning E. P., Kwekkeboom D. J., Oei H. Y., Reubi J. C., van Hagen P. M., Kooij P. P., Reijs A. E., Lamberts S. W. Somatostatin receptor imaging of endocrine gastrointestinal tumors. Schweiz Med Wochenschr. 1992 Apr 25;122(17):634–637. [PubMed] [Google Scholar]
  10. Krudy A. G., Doppman J. L., Jensen R. T., Norton J. A., Collen M. J., Shawker T. H., Gardner J. D., McArthur K., Gorden P. Localization of islet cell tumors by dynamic CT: comparison with plain CT, arteriography, sonography, and venous sampling. AJR Am J Roentgenol. 1984 Sep;143(3):585–589. doi: 10.2214/ajr.143.3.585. [DOI] [PubMed] [Google Scholar]
  11. Lamberts S. W., Bakker W. H., Reubi J. C., Krenning E. P. Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med. 1990 Nov 1;323(18):1246–1249. doi: 10.1056/NEJM199011013231805. [DOI] [PubMed] [Google Scholar]
  12. Lightdale C. J., Botet J. F., Woodruff J. M., Brennan M. F. Localization of endocrine tumors of the pancreas with endoscopic ultrasonography. Cancer. 1991 Oct 15;68(8):1815–1820. doi: 10.1002/1097-0142(19911015)68:8<1815::aid-cncr2820680828>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  13. Norrby S., Fagerberg G., Sjödahl R. Decreasing incidence of gallstone disease in a defined Swedish population. Scand J Gastroenterol. 1986 Mar;21(2):158–162. doi: 10.3109/00365528609034641. [DOI] [PubMed] [Google Scholar]
  14. Norton J. A., Doppman J. L., Collen M. J., Harmon J. W., Maton P. N., Gardner J. D., Jensen R. T. Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome. Ann Surg. 1986 Oct;204(4):468–479. doi: 10.1097/00000658-198610000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pipeleers-Marichal M., Somers G., Willems G., Foulis A., Imrie C., Bishop A. E., Polak J. M., Häcki W. H., Stamm B., Heitz P. U. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med. 1990 Mar 15;322(11):723–727. doi: 10.1056/NEJM199003153221103. [DOI] [PubMed] [Google Scholar]
  16. Päivänsalo M., Mäkäräinen H., Siniluoto T., Ståhlberg M., Jalovaara P. Ultrasound compared with computed tomography and pancreatic arteriography in the detection of endocrine tumours of the pancreas. Eur J Radiol. 1989 Aug;9(3):173–178. [PubMed] [Google Scholar]
  17. Rösch T., Braig C., Gain T., Feuerbach S., Siewert J. R., Schusdziarra V., Classen M. Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology. 1992 Jan;102(1):188–199. doi: 10.1016/0016-5085(92)91800-j. [DOI] [PubMed] [Google Scholar]
  18. Rösch T., Dittler H. J., Lorenz R., Braig C., Gain T., Feuerbach S., Höfler H., Siewert J. R., Classen M. Endosonographisches Staging des Pankreaskarzinoms. Dtsch Med Wochenschr. 1992 Apr 10;117(15):563–569. doi: 10.1055/s-2008-1062347. [DOI] [PubMed] [Google Scholar]
  19. Rösch T., Lightdale C. J., Botet J. F., Boyce G. A., Sivak M. V., Jr, Yasuda K., Heyder N., Palazzo L., Dancygier H., Schusdziarra V. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med. 1992 Jun 25;326(26):1721–1726. doi: 10.1056/NEJM199206253262601. [DOI] [PubMed] [Google Scholar]
  20. Scherübl H., Bäder M., Fett U., Hamm B., Schmidt-Gayk H., Koppenhagen K., Dop F. J., Riecken E. O., Wiedenmann B. Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors. Gastroenterology. 1993 Dec;105(6):1705–1709. doi: 10.1016/0016-5085(93)91066-q. [DOI] [PubMed] [Google Scholar]
  21. Stark D. D., Moss A. A., Goldberg H. I., Deveney C. W. CT of pancreatic islet cell tumors. Radiology. 1984 Feb;150(2):491–494. doi: 10.1148/radiology.150.2.6318260. [DOI] [PubMed] [Google Scholar]
  22. Tio T. L., Tytgat G. N. Endoscopic ultrasonography in analysing peri-intestinal lymph node abnormality. Preliminary results of studies in vitro and in vivo. Scand J Gastroenterol Suppl. 1986;123:158–163. doi: 10.3109/00365528609091878. [DOI] [PubMed] [Google Scholar]
  23. Wank S. A., Doppman J. L., Miller D. L., Collen M. J., Maton P. N., Vinayek R., Slaff J. I., Norton J. A., Gardner J. D., Jensen R. T. Prospective study of the ability of computed axial tomography to localize gastrinomas in patients with Zollinger-Ellison syndrome. Gastroenterology. 1987 Apr;92(4):905–912. doi: 10.1016/0016-5085(87)90963-2. [DOI] [PubMed] [Google Scholar]
  24. Yamada M., Komoto E., Naito Y., Tsukamoto Y., Mitake M. Endoscopic ultrasonography in the diagnosis of pancreatic islet cell tumors. J Ultrasound Med. 1991 May;10(5):271–276. doi: 10.7863/jum.1991.10.5.271. [DOI] [PubMed] [Google Scholar]
  25. Yasuda K., Mukai H., Fujimoto S., Nakajima M., Kawai K. The diagnosis of pancreatic cancer by endoscopic ultrasonography. Gastrointest Endosc. 1988 Jan-Feb;34(1):1–8. doi: 10.1016/s0016-5107(88)71220-1. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES